FNDC5/irisin mitigates the cardiotoxic impacts of cancer chemotherapeutics by modulating ROS-dependent and -independent mechanisms
Redox Biology,
Journal Year:
2025,
Volume and Issue:
80, P. 103527 - 103527
Published: Feb. 4, 2025
Cardiotoxicity
remains
a
major
limiting
factor
in
the
clinical
implementation
of
anthracycline
chemotherapy.
Though
etiology
doxorubicin-dependent
heart
damage
has
yet
to
be
fully
elucidated,
ability
doxorubicin
DNA
and
trigger
oxidative
stress
have
been
heavily
implicated
pathogenesis
chemotherapy-associated
cardiomyopathy.
Here,
we
demonstrate
that
fibronectin
type
III
domain-containing
protein
5
(FNDC5),
precursor
for
myokine
irisin,
is
depleted
hearts
human
cancer
patients
or
mice
exposed
chemotherapeutics.
In
cardiomyocytes,
restoration
FNDC5
expression
was
sufficient
mitigate
reactive
oxygen
species
(ROS)
accumulation
apoptosis
following
exposure,
effects
dependent
on
irisin
encoding
domain
as
well
signaling
via
putative
integrin
receptor.
Intriguingly,
identified
two
parallel
cascades
impacted
by
cardiomyocytes:
ROS-driven
intrinsic
mitochondrial
pathway
ROS-independent
Ataxia
Telangiectasia
Rad3-Related
Protein
(ATR)/Checkpoint
Kinase
1
(Chk1)
pathway.
fact,
forms
co-precipitable
complex
with
Chk1
alluding
possible
intracellular
actions
this
canonically
membrane-associated
protein.
Whereas
overexpression
murine
cardioprotective,
introduction
FNDC5-targeted
shRNA
into
myocardium
Bax
up-regulation,
ATR/Chk1
activation,
stress,
cardiac
fibrosis,
loss
ventricular
function,
compromised
animal
survival.
The
detrimental
impact
depletion
function
could
mitigated
treatment
inhibitor
identifying
hyperactivity
causative
disease.
our
data
point
potential
utility
FNDC5/irisin-targeted
agents
chemotherapy-induced
cardiotoxicity,
also
found
significant
down
regulation
aged
attenuated
cardioprotective
impacts
exposure.
Together
underscore
importance
FNDC5/irisin
maintenance
health
over
lifespan.
Language: Английский
Irisin Alleviates Impaired Mitochondrial Fusion via Enhancing PKA/SIRT3/mTOR Pathway in Hepatic Steatosis
Journal of Gastroenterology and Hepatology,
Journal Year:
2025,
Volume and Issue:
unknown
Published: April 2, 2025
Hepatic
steatosis,
a
hallmark
of
metabolic
dysfunction-associated
steatotic
liver
disease
(MASLD),
arises
from
disrupted
lipid
homeostasis.
Mitochondrial
dysfunction,
particularly
imbalances
in
mitochondrial
fusion
and
fission,
plays
crucial
role
MASLD
progression.
Irisin,
an
exercise-induced
myokine,
is
involved
metabolism,
though
its
precise
mechanisms
action
remain
unclear.
An
irisin-Fc
protein
was
prophylactically
administered
to
mice
with
high-fat
diet
(HFD)-induced
for
12
weeks.
Liver
tissues
were
analyzed
using
oil
red
O
staining
hepatic
serum
profiling
evaluate
irisin's
therapeutic
efficacy.
Expression
levels
proteins
fatty
acid
metabolism
dynamics
assessed.
In
palmitate
(PA)-treated
HepG2
cells,
morphology
analyzed,
uptake
determined
through
colocalization
fluorescently
labeled
PA
mitochondria.
PKA
activity
SIRT3
expression
validated
agonist/inhibitor
overexpression
or
knockdown
via
plasmid
transfection
siRNA.
Irisin
significantly
reduced
accumulation
HFD-induced
mouse
models
PA-treated
cells.
These
effects
associated
enhanced
fusion,
indicated
by
increased
mitofusin
2
optic
atrophy
type
1
excessive
evidenced
decreased
activation
dynamin-related
1.
changes
mediated
partly
PKA/SIRT3/mTOR
pathway
activation,
which
facilitated
β-oxidation
while
inhibiting
lipogenesis.
Our
results
demonstrate
the
protective
irisin
alleviating
steatosis
regulating
dynamics.
findings
provide
valuable
evidence
antisteatogenic
potential
management.
Language: Английский
The molecular determinants regulating redox signaling in diabetic endothelial cells
Swayam Prakash Srivastava,
No information about this author
Olivia Kopasz-Gemmen,
No information about this author
Aaron Thurman
No information about this author
et al.
Frontiers in Pharmacology,
Journal Year:
2025,
Volume and Issue:
16
Published: April 1, 2025
Oxidation
and
reduction
are
vital
for
keeping
life
through
several
prime
mechanisms,
including
respiration,
metabolism,
other
energy
supplies.
Mitochondria
considered
the
cell’s
powerhouse
use
nutrients
to
produce
redox
potential
generate
ATP
H
2
O
process
of
oxidative
phosphorylation
by
operating
electron
transfer
proton
pumping.
Simultaneously,
mitochondria
also
oxygen
free
radicals,
called
superoxide
(O
−
),
non-enzymatically,
which
interacts
with
moieties
reactive
species
(ROS),
such
as
hydrogen
peroxide
(H
peroxynitrite
(ONOO−),
hydroxyl
radical
(OH
).
These
modify
nucleic
acids,
proteins,
carbohydrates
ultimately
cause
damage
organs.
The
nutrient-sensing
kinases,
AMPK
mTOR,
function
a
key
regulator
cellular
ROS
levels,
loss
or
aberrant
activation
mTOR
signaling
causes
production
compromises
oxidant
status,
resulting
in
various
injuries.
increased
not
only
directly
damages
DNA,
lipids
but
alters
pathways,
MAPK
PI3K,
accumulation
HIF-1α
nucleus,
NFkB-mediated
transcription
pro-inflammatory
cytokines.
factors
mesenchymal
renal
endothelial
cells.
Here,
we
discuss
biology
that
underlies
pathophysiology
diabetic
Language: Английский
Irisin levels in type 2 diabetes mellitus with and without non-alcoholic fatty liver disease: a case-control study
Saffalya Nayak,
No information about this author
Pratima Kumari Sahu,
No information about this author
Roma Rattan
No information about this author
et al.
Prospects in Pharmaceutical Sciences,
Journal Year:
2024,
Volume and Issue:
22(3), P. 210 - 218
Published: Sept. 26, 2024
Background:
Fatty
liver
disease,
particularly
non-alcoholic
fatty
disease
(NAFLD),
affects
around
25%
of
adults
globally
and
up
to
40%
in
developed
countries.
Often
coexisting
with
type
2
diabetes
mellitus
(T2DM),
NAFLD
is
linked
insulin
resistance
metabolic
syndrome.
Irisin,
a
myokine
induced
by
exercise,
shows
promise
enhancing
sensitivity,
reducing
hepatic
steatosis,
improving
health.
Despite
its
potential,
further
research
needed
fully
understand
irisin's
mechanisms
clinical
implications
T2DM.
Objectives:
This
study
investigates
the
irisin
levels
T2DM
patients
without
compares
them
healthy
controls.
Methods:
A
case-control
has
been
conducted
involving
90
controls,
aged
30-55
years,
recruited
from
SCB
Medical
College,
Cuttack,
between
September
2021
August
2022.
Participants
were
screened
for
using
Hepatosis
Steatosis
Index
(HSI)
divided
into
four
groups:
NAFLD,
controls
NAFLD.
Serum
measured
ELISA.
Anthropometric
data,
physical
activity,
various
biochemical
parameters
assessed
analyzed.
Results:
The
significantly
lower
compared
(p
=
0.001).
Among
patients,
those
had
than
though
not
statistically
significant
0.299).
Significant
correlations
observed
sensitivity
markers
such
as
HOMA-IR
QUICKI
across
different
groups.
Conclusion:
Lower
highlight
potential
role
pathogenesis
disorders.
Further
elucidate
therapeutic
Language: Английский